Table of Content

1 Nuclear Medicine/Radiopharmaceutic Market Introduction and Overview
1.1 Nuclear Medicine/Radiopharmaceutic Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Nuclear Medicine/Radiopharmaceutic Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type
3 Global Nuclear Medicine/Radiopharmaceutic Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size (2019-2024)
4.2 Nuclear Medicine/Radiopharmaceutic Growth Trends Analysis by Regions
4.2.1 Nuclear Medicine/Radiopharmaceutic Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Nuclear Medicine/Radiopharmaceutic Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Nuclear Medicine/Radiopharmaceutic Market Size (2019-2024)
4.2.4 Europe Nuclear Medicine/Radiopharmaceutic Market Size (2019-2024)
4.2.5 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Size (2019-2024)
4.2.6 Latin America Nuclear Medicine/Radiopharmaceutic Market Size (2019-2024)
4.2.7 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Market Size (2019-2024)
5 North America
5.1 North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries
5.1.1 North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2019-2024)
5.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Types
5.3 North America Nuclear Medicine/Radiopharmaceutic Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Countries
6.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2019-2024)
6.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Types
6.3 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries
7.1.1 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2019-2024)
7.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Types
7.3 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Countries
8.1.1 Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2019-2024)
8.2 Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Types
8.3 Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries
9.1.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2019-2024)
9.2 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Types
9.3 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Nuclear Medicine/Radiopharmaceutic Market Competition, by Players
10.1 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Nuclear Medicine/Radiopharmaceutic Players Market Share in 2023
10.2.2 Top 6 Nuclear Medicine/Radiopharmaceutic Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Nuclear Medicine/Radiopharmaceutic Players Head Office, Business Provided
10.4 Nuclear Medicine/Radiopharmaceutic Mergers & Acquisitions
10.5 Nuclear Medicine/Radiopharmaceutic New Entrants and Expansion Plans
11 Players Profiles11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Profile
11.1.2 Nuclear Medicine/Radiopharmaceutic Product Overview
11.1.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
11.1.4 Bracco Imaging Business Overview
11.1.5 Recent Developments and Plans
11.2 Bayer
11.2.1 Bayer Company Profile
11.2.2 Nuclear Medicine/Radiopharmaceutic Product Overview
11.2.3 Bayer Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
11.2.4 Bayer Business Overview
11.2.5 Recent Developments and Plans
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Profile
11.3.2 Nuclear Medicine/Radiopharmaceutic Product Overview
11.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
11.3.4 Mallinckrodt Business Overview
11.3.5 Recent Developments and Plans
11.4 Nordion
11.4.1 Nordion Company Profile
11.4.2 Nuclear Medicine/Radiopharmaceutic Product Overview
11.4.3 Nordion Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
11.4.4 Nordion Business Overview
11.4.5 Recent Developments and Plans
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Profile
11.5.2 Nuclear Medicine/Radiopharmaceutic Product Overview
11.5.3 Triad Isotopes Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
11.5.4 Triad Isotopes Business Overview
11.5.5 Recent Developments and Plans
11.6 Lantheus
11.6.1 Lantheus Company Profile
11.6.2 Nuclear Medicine/Radiopharmaceutic Product Overview
11.6.3 Lantheus Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
11.6.4 Lantheus Business Overview
11.6.5 Recent Developments and Plans
11.7 IBA Group
11.7.1 IBA Group Company Profile
11.7.2 Nuclear Medicine/Radiopharmaceutic Product Overview
11.7.3 IBA Group Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
11.7.4 IBA Group Business Overview
11.7.5 Recent Developments and Plans
11.8 GE Healthcare
11.8.1 GE Healthcare Company Profile
11.8.2 Nuclear Medicine/Radiopharmaceutic Product Overview
11.8.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
11.8.4 GE Healthcare Business Overview
11.8.5 Recent Developments and Plans
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Company Profile
11.9.2 Nuclear Medicine/Radiopharmaceutic Product Overview
11.9.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
11.9.4 China Isotope & Radiation Business Overview
11.9.5 Recent Developments and Plans
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Company Profile
11.10.2 Nuclear Medicine/Radiopharmaceutic Product Overview
11.10.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
11.10.4 Jubilant Pharma Business Overview
11.10.5 Recent Developments and Plans
11.11 Eli Lilly
11.11.1 Eli Lilly Company Profile
11.11.2 Nuclear Medicine/Radiopharmaceutic Product Overview
11.11.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Market Performance (2019-2024)
11.11.4 Eli Lilly Business Overview
11.11.5 Recent Developments and Plans
12 Global Nuclear Medicine/Radiopharmaceutic Forecast Market Analysis by Type
12.1 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Forecast by Type (2024-2030)
13 Global Nuclear Medicine/Radiopharmaceutic Forecast Market Analysis by Application
13.1 Nuclear Medicine/Radiopharmaceutic Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Nuclear Medicine/Radiopharmaceutic Forecast Market Size (2024-2030)
14.2 Nuclear Medicine/Radiopharmaceutic Growth Trends Forecast Analysis by Regions
14.2.1 Nuclear Medicine/Radiopharmaceutic Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Nuclear Medicine/Radiopharmaceutic Forecast Market Size (2024-2030)
14.2.3 Europe Nuclear Medicine/Radiopharmaceutic Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Forecast Market Size (2024-2030)
14.2.5 Latin America Nuclear Medicine/Radiopharmaceutic Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Forecast Market Size (2024-2030)
15 Nuclear Medicine/Radiopharmaceutic Industry Dynamic Analysis
15.1 Nuclear Medicine/Radiopharmaceutic Market Trends Analysis
15.2 Nuclear Medicine/Radiopharmaceutic Market Drivers Analysis
15.3 Nuclear Medicine/Radiopharmaceutic Market Challenges Analysis
15.4 Nuclear Medicine/Radiopharmaceutic Market Restraints Analysis